Yuan Liu
Assoc Professor
Research Associate Professor
Faculty, Biostatistics and Bioinformatics
With an overall 12 years’ in-depth collaborations in medical/cancer/public health research, Dr. Liu holds over 160 peer-reviewed publications and served as a lead biostatistician in variety grant proposals (e.g., R01, P01, SPORE, U54). She has a broad spectrum of experiences and expertises in cancer research, such as cancer outcome research based on national cancer registry databases, Causal inference based on observational studies, cancer risk stratification and validation, dynamic prognostic biomarker development for early cancer diagnosis, optimal treatment region, and phase I and II clinical trial design. She determines to bridge the statistical innovation to clinical research, to promote high standards in research with quality and efficiency in collaboration, and to challenge students to gain real-life skills and to be independent. She also initiated an efficient collaborative framework and analytic workflow for NCDB related collaboration and created a sequential high-performance SAS macro for streamlined data analysis. Dr. Liu is currently served as the Biostatistics and Bioinformatics Core director for Emory Lung P01.
Contact Information
Biostatistics Shared Core Resource at WCI ,
Atlanta , GA 30322
GCR 352, 1518 Clifton Rd.
Phone: (404)778-1989
Fax: (404)778-5016
Email: yliu31@emory.edu
Areas of Interest
- Biomarkers
- Cancer Prevention
- Clinical Trials
- Health Outcomes
- Longitudinal Analysis
- Survival Analysis
Education
- Ph.D. 2008, University of South Carolina
- M.S. 2004, University of North Carolina
- B.S. 1998, National Huaqiao University
Courses Taught
- BIOS 530: Observational Studies
Publications
- Shaib WL, Manali R, Liu Y, El-Rayes B, Loehrer P, O'Neil B, Cohen S, Khair T, Robin E, Huyck T, Bekaii-Saab T, 2023, Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198), Eur J Cancer, ,
- Zhuang TZ, Ravindranathan D, Liu Y, Martini DJ, Brown JT, Nazha B, Russler G, Yantorni LB, Caulfield S, Carthon BC, Kucuk O, Master VA, Bilen MA., 2023, Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors., Oncologist, 28, 239-245
- Patel SA, Liu Y, Solanki AA, Baumann BC, Efstathiou JA, Jani AB, Chang AJ, Fischer-Valuck B, Royce TJ, 2023, Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer, Urol Oncol., 41, 325
- Schmeusser BN, Manalo TA, Liu Y, Shah YB, Ali A, Armas-Phan M, Patil DH, Nabavizadeh R, Ogan K, Master VA, 2023, Mayo Adhesive Probability Score Does Not Have Prognostic Ability in Locally Advanced Renal Cell Carcinoma, J Kidney Cancer VHL, 10, 19-25
- Bilen MA, Akintayo A, Liu Y, Abiodun-Ojo O, Kucuk O, Carthon BC, Schuster DM, Parent EE., 1945, Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT. , Cancers (Basel), 8, 14